연구동향 분석

A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease

양영순 최호진 이찬녕 김용범 YongTaeKwak 2018년

논문상세정보
인용/피인용

' A Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial for Efficacy of Acetyl-L-carnitine in Patients with Dementia Associated with Cerebrovascular Disease' 의 참고문헌

  • Vascular factors and Alzheimer disease
    Skoog I [1999]
  • Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association
    Gorelick PB [2011]
  • Vascular cognitive impairment
  • Validity and applications of the Montreal cognitive assessment for the assessment of vascular cognitive impairment
    Koski L [2013]
  • The pathology of "vascular dementia": a critical update
  • Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease
    Scacchi R [2014]
  • Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank
    Barker WW [2002]
  • Recommendations guiding physicians in biomedical research involving human subjects
  • Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales
  • Overlap between pathology of Alzheimer disease and vascular dementia
    Kalaria RN [1999]
  • Mixed brain pathologies account for most dementia cases in community-dwelling older persons
  • Meta-analysis of double blind randomised controlled clinical trials acetyl-lcarnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
  • L-carnitine and potential protective effects against ischemiareperfusion injury in noncardiac organs: from experimental data to potential clinical applications
    Moghaddas A [2017]
  • Involvement of angiotensin converting enzyme in cerebral hypoperfusion induced anterograde memory impairment and cholinergic dysfunction in rats
    Kumaran D [2008]
  • Evaluation of efficacy of chronic administration (6 months) of acetyl-l-carnitine in patients suffering from Senile Dementia Alzheimer Type (SDAT) and Alzheimer Disease (AD) statistical report, study protocol no.: ST20032189 (DRN4-021), on file Sigma-Tau (unpublished data)
    Onofrj M [1992]
  • Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials
    Kavirajan H [2007]
  • Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease
    Sano M [1992]
  • Differences in rate of functional decline across three dementia types
    Gill DP [2013]
  • Clinical pharmacodynamics of acetyl-L-carnitine in patients with Parkinson's disease
    Puca FM [1990]
  • Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment
    Lee JY [2008]
  • Amitriptyline and clomipramine activate Gi-protein signaling pathway in the induction of analgesia
  • Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression
  • Acetyl-L-carnitine in hepatic encephalopathy
  • Acetyl-L-carnitine for dementia
    Hudson S [2003]
  • Acetyl-L-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats
    Imperato A [1989]